A combination of broad neutralizing antibodies efficiently protects from in vitro cell-associated SHIV162P3 transmission
Karunasinee Suphaphiphat,
Monica Tolazzi,
Céline Gommet,
Nathalie Bosquet,
Gabriella Scarlatti,
Roger Le Grand,
Mariangela Cavarelli
Affiliations
Karunasinee Suphaphiphat
CEA-University Paris Sud-INSERM U1184, Infectious Disease Models for Innovative Therapies (IDMIT), Fontenay-Aux-Roses France
Monica Tolazzi
Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
Céline Gommet
CEA-University Paris Sud-INSERM U1184, Infectious Disease Models for Innovative Therapies (IDMIT), Fontenay-Aux-Roses France
Nathalie Bosquet
CEA-University Paris Sud-INSERM U1184, Infectious Disease Models for Innovative Therapies (IDMIT), Fontenay-Aux-Roses France
Gabriella Scarlatti
Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
Roger Le Grand
CEA-University Paris Sud-INSERM U1184, Infectious Disease Models for Innovative Therapies (IDMIT), Fontenay-Aux-Roses France
Mariangela Cavarelli
CEA-University Paris Sud-INSERM U1184, Infectious Disease Models for Innovative Therapies (IDMIT), Fontenay-Aux-Roses France
